Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications how zoonotic disease surveillance can influence evidence based policy decisions one
… manufacturers consider what information and evidence they can submit in support of their products, should they be … Alternative Treatments.” In the analysis below we explore how the optional elements in Section I have changed in the … and preferences, treatment burden, and burden of disease. Another important addition to the ICR for IPAY 2027 …
… Evidence Assessment for a Digital Medical Technology … in the United Kingdom and was not recommended for use based on insufficient clinical evidence. CHALLENGE The client’s digital diagnostic technology was in a busy disease area with multiple guidelines. This made …
… Workshop hosted by the Duke-Margolis Center for Health Policy under a cooperative agreement with the FDA. Dr. Layton …
… Integrated Evidence Generation Strategy Long-Range Planning for Improved … are aligned to budget cycles and functional area silos can lead to evidence gaps, duplication, inefficiency, and a … Consolidating plans to form an asset-level IEG plan can help you minimize development time and costs, avoid …
… as possible after diagnosis. Genomic/biomarker evaluations can not only help identify the best treatments for patients, … these data for research purposes, such as understanding how their product performs in real-world settings, … discussion points. The Growing Importance of Real-World Evidence The conference highlighted the increasing relevance …
… may consider it an opportunity to introduce the disease and unmet need, with minimal focus on ongoing or … and which data from these studies is essential to include? How will the inclusion of clinical data affect planned or pending publications? Manufacturers should determine the appropriate …
… JCA Evidence Preparation and Support For successful marketing … to support your product. We have an experienced team that can provide high quality, unbiased research that will stand up to scrutiny and support your objectives. We can assist you with: Epidemiology Patient perspective unmet …
… 2019 Watch the recording When seeking approval for rare disease products, demonstrating value for therapies can be a challenge. The limited amount of data available … webinar where you’ll learn: Health Technology Assessment: How do HTA bodies define rare or ultra-orphan diseases? How …
… Infectious Disease Models Utilize the power of infectious disease models … Static health economic models are a useful tool, but they can only assess the direct impact of an intervention. When … to present your product to its full potential. Understand how your intervention affects disease transmission, health …
… GDPR compliance framework described here demonstrates how we have implemented the requirements for data protection. … regarding how RTI-HS collects and uses personal data based on website visits. The Website Privacy Policy provides … data is used. The Cookie Policy clearly explains how users can manage preferences for cookies, including how to withdraw …